¿Son útiles los factores pronóstico en la artritis reumatoide?
Tài liệu tham khảo
Spector, 1990, Rheumatoid arthritis, Rheum Dis Clin North Am, 16, 513, 10.1016/S0889-857X(21)00886-3
Mau, 1991, Prediction of permanent work disability in a follow-up study of early rheumatoid arthritis: results of a tree structured analysis using recpam, Mau Semin Arthritis Rheum, 21, 4
Schneeberger, 2010, Factors associated with disability in patients with rheumatoid arthritis, J Clin Rheumatol, 16, 215, 10.1097/RHU.0b013e3181e92d25
Hetland, 2010, Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial, Ann Rheum Dis, 69, 1789, 10.1136/ard.2009.125534
Vvan Tuyl, 2010, European League against Rheumatism Committee to Define Remission for Clinical Trials. Evidence for predictive validity of remission on long-term outcome in rheumatoid arthritis: a systematic review, Arthritis Care Res, 62, 108, 10.1002/acr.20021
Sanmarti, 2003, Radiological progression in early rheumatoid arthritis after DMARDS: a one-year follow-up study in a clinical setting, Rheumatology, 42, 1044, 10.1093/rheumatology/keg284
Gorman, 2004, Lack of association of the HLA-DRB1 shared epitope with rheumatoid nodules: an individual patient data meta-analysis of 3,272 caucasian patients with rheumatoid arthritis, Arthritis Rheum, 50, 753, 10.1002/art.20119
Katchamart, 2010, Predictors for remission in rheumatoid arthritis patients: A systematic review, Arthritis Care Res, 62, 1128, 10.1002/acr.20188
Van der Heijde, 2005, Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial, Ann Rheum Dis, 65, 328, 10.1136/ard.2005.035709
Burmester, 2008, Clinical remission and/or minimal disease activity in patients receiving adalimumab treatment in a multinational, open-label, twelve-week study, Arthritis Rheum, 59, 32, 10.1002/art.23247
Pease, 1999, Does the age of onset of rheumatoid arthritis influence phenotype?: a prospective study of outcome and prognostic factors, Rheumatology, 38, 228, 10.1093/rheumatology/38.3.228
Molenaar, 2002, Influence of HLA polymorphism on persistent remission in rheumatoid arthritis, Ann Rheum Dis, 61, 351, 10.1136/ard.61.4.351
Hyrich, 2006, British Society for Rheumatology Biologics R. Predictors of response to anti-TNF-alpha therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register, Rheumatology, 45, 1558, 10.1093/rheumatology/kel149
Gossec, 2004, Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study, Ann Rheum Dis, 63, 675, 10.1136/ard.2003.010611
Forslind, 2007, Sex: a major predictor of remission in early rheumatoid arthritis?, Ann Rheum Dis, 66, 46, 10.1136/ard.2006.056937
Van der Heijde, 2007, Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis, Arthritis Rheum, 56, 3928, 10.1002/art.23141
Mottonen, 2002, Delay to institution of therapy and induction of remission using single-drug or combination-disease modifying antirheumatic drug therapy in early rheumatoid arthritis, Arthritis Rheum, 46, 894, 10.1002/art.10135
Radovits, 2010, Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis, Arth Care Res, 62, 362, 10.1002/acr.20105
Gonzalez, 2007, The widening mortality gap between rheumatoid arthritis patients and the general population, Arth Rheumat, 56, 3583, 10.1002/art.22979
Actualización de guía de práctica clínica para el manejo de la artritis reumatoide (GUIPCAR) en España 2007.